8104.0 - Research and Experimental Development, Businesses, Australia, 2003-04
ARCHIVED ISSUE Released at 11:30 AM (CANBERRA TIME) 28/09/2005
|Page tools: Print Page Print All|
Business spending on R&D increases for fourth successive year
Business expenditure on research and experimental development (R&D) increased by 10% between 2002-03 and 2003-04, to $7.22 billion.
With the effect of changes in prices, wages and salaries removed (ie chain volume measures), business expenditure on R&D increased by 7% in 2003-04, the fourth successive year of increases.
As a percentage of Gross Domestic Product, business expenditure on R&D was 0.89%, higher than the 0.87% recorded in both 2002-03 and 2001-02.
Businesses in the manufacturing and the property and business services industries were the largest contributors to total R&D expenditure, with 46% and 23% of the total estimate respectively.
Businesses with fewer than 50 employees contributed 26% of the total estimate, while businesses with greater than 1,000 employees contributed 35%.
R&D expenditure was highest in New South Wales ($2,716m), followed by Victoria ($2,072m). Expenditure in these states contributed 38% and 29% of the total estimate respectively. South Australia had the highest level of expenditure as a percentage of Gross State Product at 1.07%, followed by Victoria with 1.0%.
Information on biotechnology related R&D was collected in 2003-04. There were 304 businesses who performed biotechnology related R&D, or paid another to perform it on their behalf. Total expenditure on biotechnology related R&D was $377.8m.
Property and business services was the largest industry involved in biotechnology related R&D, contributing 71%.
Further information is in Research and Experimental Development, Businesses, Australia, 2003-04 (cat. no. 8104.0).
These documents will be presented in a new window.